GSK's former global headquarters on the Great West Road in Brentford, west London. Health GSK's Jemperli shows 76 percent complete response in rectal cancer trial, days after FDA approval Mono Scoops 2d GSK's Jemperli produced a complete response in 76 percent of evaluable patients with MSI-H/dMMR locally advanced rectal cancer in the AZUR-1 trial, with full data presented at ESMO days after FDA approval. Read Full Story
